BioRestorative Therapies (BRTX) FCF Margin (2012 - 2026)
BioRestorative Therapies (BRTX) recorded FCF Margin of -16434.15% in Q1 2026, down 5173.40 percentage points from -11260.74% a year earlier and down 3782.78 percentage points from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) FCF Margin (2012 - 2026) Analysis & Trends
On a TTM basis, BioRestorative Therapies' FCF Margin came in at -3327.65% as of Mar 31, 2026, down 1077.36 percentage points year-over-year; for FY2025, it was -3034.77%, down 955.83 percentage points from FY2024.
- Annual FCF Margin has a five-year change of -483.78 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at -2078.94% in FY2024 (+2448.67 pp), -4527.61% in FY2023 (+629.59 pp), -5157.20% in FY2022 (+2148.38 pp) and -7305.58% in FY2021 (-4754.58 pp).
- Quarterly FCF Margin has ranged from -44818.08% in Q4 2022 to -752.57% in Q3 2024 over the past five years.
- On a year-over-year basis, FCF Margin has declined for three consecutive quarters, with an average year-over-year change of -4178.81 percentage points over the last eight quarters.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 36227.48 percentage points in Q4 2023, against a drop of 23823.70 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -12651.37% (Q4 2025), -24576.27% (Q3 2025) and -897.20% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | -16,434.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -16,434.15% |
| Dec 31, 2025 | -12,651.37% |
| Sep 30, 2025 | -24,576.27% |
| Jun 30, 2025 | -897.20% |
| Mar 31, 2025 | -11,260.74% |
| Dec 31, 2024 | -5,450.99% |
| Sep 30, 2024 | -752.57% |
| Jun 30, 2024 | -2,093.34% |
| Mar 31, 2024 | -6,622.23% |
| Dec 31, 2023 | -8,590.60% |
| Sep 30, 2023 | -3,880.67% |
| Jun 30, 2023 | -2,035.04% |
| Mar 31, 2023 | -7,793.29% |
| Dec 31, 2022 | -44,818.08% |
| Sep 30, 2022 | -4,920.87% |
| Jun 30, 2022 | -1,953.30% |
| Mar 31, 2022 | -10,651.29% |
| Dec 31, 2021 | -22,900.28% |
| Sep 30, 2021 | -7,867.05% |
| Jun 30, 2021 | -4,945.53% |
API Access
BioRestorative Therapies FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();